Amneal Pharmaceuticals Inc. (AMRX)
NASDAQ · Healthcare
Amneal Pharmaceuticals Inc. Long Term Debt 2016–2025
Amneal Pharmaceuticals Inc. annual/quarterly long term debt history from 2017 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Amneal Pharmaceuticals Inc. long term debt for the quarter ending December 31, 2025 were 2.57B, a 7.79% increase year-over-year.
- Amneal Pharmaceuticals Inc. long term debt for 2025 were 2.57B, a 7.79% increase from 2024.
- Amneal Pharmaceuticals Inc. long term debt for 2024 were 2.39B, a 1.41% decrease from 2023.
- Amneal Pharmaceuticals Inc. long term debt for 2023 were 2.42B, a 7.70% decrease from 2022.
- Amneal Pharmaceuticals Inc. long term debt for 2022 were 2.62B.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Amneal Pharmaceuticals Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $2,572 |
| 2024 | $2,386 |
| 2023 | $2,420 |
| 2022 | $2,622 |
| 2021 | $2,711 |
| 2020 | $2,779 |
| 2019 | $2,631 |
| 2018 | $2,652 |
| 2017 | $1,444 |
| Amneal Pharmaceuticals Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $2,572 |
| 2024-12-31 | $2,386 |
| 2023-12-31 | $2,420 |
| 2022-12-31 | $2,622 |
| 2021-12-31 | $2,711 |
| 2020-12-31 | $2,779 |
| 2019-12-31 | $2,631 |
| 2018-12-31 | $2,652 |
| 2017-12-31 | $1,444 |
Amneal Pharmaceuticals Inc. Long Term Debt — FAQ
Amneal Pharmaceuticals Inc. (AMRX) long term debt over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AMRX's long term debt history?
The chart and table above show Amneal Pharmaceuticals Inc.'s long term debt by year and by quarter, including the growth rate.